CY1429A - Quick disintegrating pressed shapes containing pharmaceutical active substances - Google Patents
Quick disintegrating pressed shapes containing pharmaceutical active substances Download PDFInfo
- Publication number
- CY1429A CY1429A CY1429A CY142988A CY1429A CY 1429 A CY1429 A CY 1429A CY 1429 A CY1429 A CY 1429A CY 142988 A CY142988 A CY 142988A CY 1429 A CY1429 A CY 1429A
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical active
- active substances
- quick
- disintegrating
- containing pharmaceutical
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title claims abstract 24
- 239000000203 mixture Substances 0.000 claims abstract 6
- 239000003795 chemical substances by application Substances 0.000 claims abstract 4
- 230000003111 delayed effect Effects 0.000 claims abstract 3
- 239000001856 Ethyl cellulose Substances 0.000 claims abstract 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims abstract 2
- 229920001249 ethyl cellulose Polymers 0.000 claims abstract 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims abstract 2
- 229920000058 polyacrylate Polymers 0.000 claims abstract 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical group [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 4
- 239000011248 coating agent Substances 0.000 claims 3
- 238000000576 coating method Methods 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- 239000001103 potassium chloride Substances 0.000 claims 2
- 235000011164 potassium chloride Nutrition 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- 229920003086 cellulose ether Polymers 0.000 claims 1
- 229960001193 diclofenac sodium Drugs 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000008240 homogeneous mixture Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- PIDSZXPFGCURGN-UHFFFAOYSA-N pirprofen Chemical group ClC1=CC(C(C(O)=O)C)=CC=C1N1CC=CC1 PIDSZXPFGCURGN-UHFFFAOYSA-N 0.000 claims 1
- 229960000851 pirprofen Drugs 0.000 claims 1
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 claims 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 1
- 230000000979 retarding effect Effects 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical group [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Blow-Moulding Or Thermoforming Of Plastics Or The Like (AREA)
- Control Of Presses (AREA)
- Fertilizing (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Golf Clubs (AREA)
- Measurement Of Force In General (AREA)
- Dental Preparations (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH839380 | 1980-11-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1429A true CY1429A (en) | 1988-09-02 |
Family
ID=4339640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY1429A CY1429A (en) | 1980-11-12 | 1988-09-02 | Quick disintegrating pressed shapes containing pharmaceutical active substances |
Country Status (20)
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3314003A1 (de) * | 1983-04-18 | 1984-10-18 | Boehringer Ingelheim KG, 6507 Ingelheim | Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung |
| CH658188A5 (de) * | 1984-03-23 | 1986-10-31 | Ciba Geigy Ag | Lagerstabile schnellzerfallende pharmazeutische presslinge. |
| JPS6144811A (ja) * | 1984-08-10 | 1986-03-04 | Ss Pharmaceut Co Ltd | 徐放性ジクロフエナクナトリウム製剤 |
| ES8801121A1 (es) * | 1985-02-19 | 1988-01-01 | Key Pharma | Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico. |
| JPS61210025A (ja) * | 1985-03-14 | 1986-09-18 | Teisan Seiyaku Kk | 安定化された抗生物質複合顆粒製剤 |
| JPH0830005B2 (ja) * | 1985-09-25 | 1996-03-27 | ゲルゲリイ、ゲルハルト | 崩壊性錠剤とその製造方法 |
| KR880701098A (ko) * | 1986-04-01 | 1988-07-25 | 로버어트 에이 아미테이지 | 메틸프레드니솔론/소디움 카르복시메틸 전분 정제 조성물 |
| GB8628359D0 (en) * | 1986-11-27 | 1986-12-31 | Zyma Sa | Galenical formulation |
| GB8702411D0 (en) * | 1987-02-03 | 1987-03-11 | Zyma Sa | Swellable pellets |
| GB8707421D0 (en) * | 1987-03-27 | 1987-04-29 | Wellcome Found | Pharmaceutical formulations |
| GB8707416D0 (en) * | 1987-03-27 | 1987-04-29 | Wellcome Found | Pharmaceutical formulations |
| GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
| CH675537A5 (enrdf_load_stackoverflow) * | 1988-03-25 | 1990-10-15 | Ciba Geigy Ag | |
| JPH0273011A (ja) * | 1988-07-28 | 1990-03-13 | Warner Lambert Co | 医薬投与剤型製造用のセルロースおよびアクリル系重合体の水性重合体分散体およびその投与剤型 |
| JP2514078B2 (ja) * | 1988-08-22 | 1996-07-10 | エスエス製薬株式会社 | 圧縮成型製剤 |
| US5556639A (en) * | 1991-01-30 | 1996-09-17 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| US6245351B1 (en) | 1996-03-07 | 2001-06-12 | Takeda Chemical Industries, Ltd. | Controlled-release composition |
| FR2766089B1 (fr) * | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
| WO2005013964A1 (ja) | 2003-08-08 | 2005-02-17 | Ajinomoto Co., Inc. | ナテグリニド含有製剤 |
| JP5122380B2 (ja) * | 2008-06-16 | 2013-01-16 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 薬物の放出を制御した速崩錠及びその製法 |
| EP2253306A1 (en) * | 2009-05-18 | 2010-11-24 | Royal College of Surgeons in Ireland | Orodispersible dosage forms containing solid drug dispersions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
| US4143129A (en) * | 1975-10-11 | 1979-03-06 | Lilly Industries Limited | Cephalexin tablets |
| GB1560475A (en) * | 1975-10-11 | 1980-02-06 | Lilly Industries Ltd | Pharmaceutical formulation |
| US4140756A (en) * | 1976-06-10 | 1979-02-20 | Mead Johnson & Company | Film-coated matrix core tablet |
-
1981
- 1981-11-06 AT AT81810444T patent/ATE13486T1/de active
- 1981-11-06 DE DE8181810444T patent/DE3170764D1/de not_active Expired
- 1981-11-06 EP EP81810444A patent/EP0052076B1/de not_active Expired
- 1981-11-09 FI FI813532A patent/FI76254C/fi not_active IP Right Cessation
- 1981-11-10 GR GR66484A patent/GR76337B/el unknown
- 1981-11-10 IL IL64255A patent/IL64255A0/xx not_active IP Right Cessation
- 1981-11-10 ES ES506981A patent/ES8303090A1/es not_active Expired
- 1981-11-10 GB GB8133813A patent/GB2086725B/en not_active Expired
- 1981-11-10 CA CA000389815A patent/CA1178202A/en not_active Expired
- 1981-11-11 AU AU77382/81A patent/AU552861B2/en not_active Ceased
- 1981-11-11 NZ NZ198937A patent/NZ198937A/en unknown
- 1981-11-11 IE IE2643/81A patent/IE51827B1/en not_active IP Right Cessation
- 1981-11-11 DK DK499181A patent/DK154537C/da not_active IP Right Cessation
- 1981-11-11 ZA ZA817795A patent/ZA817795B/xx unknown
- 1981-11-11 PT PT73963A patent/PT73963B/pt not_active IP Right Cessation
- 1981-11-11 NO NO813826A patent/NO157964C/no unknown
- 1981-11-12 JP JP56180429A patent/JPS57109715A/ja active Granted
-
1987
- 1987-12-30 MY MY132/87A patent/MY8700132A/xx unknown
-
1988
- 1988-07-14 HK HK533/88A patent/HK53388A/xx unknown
- 1988-09-02 CY CY1429A patent/CY1429A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR76337B (enrdf_load_stackoverflow) | 1984-08-04 |
| DK499181A (da) | 1982-05-13 |
| AU552861B2 (en) | 1986-06-26 |
| EP0052076B1 (de) | 1985-05-29 |
| GB2086725B (en) | 1985-08-21 |
| PT73963B (de) | 1983-11-23 |
| AU7738281A (en) | 1982-05-20 |
| HK53388A (en) | 1988-07-22 |
| JPH0228564B2 (enrdf_load_stackoverflow) | 1990-06-25 |
| ATE13486T1 (de) | 1985-06-15 |
| DK154537B (da) | 1988-11-28 |
| JPS57109715A (en) | 1982-07-08 |
| EP0052076A1 (de) | 1982-05-19 |
| FI813532L (fi) | 1982-05-13 |
| ES506981A0 (es) | 1983-02-01 |
| IL64255A0 (en) | 1982-02-28 |
| MY8700132A (en) | 1987-12-31 |
| DE3170764D1 (en) | 1985-07-04 |
| NO813826L (no) | 1982-05-13 |
| PT73963A (de) | 1981-12-01 |
| DK154537C (da) | 1989-04-17 |
| CA1178202A (en) | 1984-11-20 |
| IE812643L (en) | 1982-05-12 |
| GB2086725A (en) | 1982-05-19 |
| NO157964C (no) | 1988-06-29 |
| FI76254B (fi) | 1988-06-30 |
| NO157964B (no) | 1988-03-14 |
| IE51827B1 (en) | 1987-04-01 |
| FI76254C (fi) | 1988-10-10 |
| NZ198937A (en) | 1985-04-30 |
| ES8303090A1 (es) | 1983-02-01 |
| ZA817795B (en) | 1982-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4666703A (en) | Storage-stable, quick-disintegrating pressed shapes containing pharmaceutical active substances | |
| CA1178202A (en) | Quick-disintegrating pressed shapes containing pharmaceutical active substances | |
| US4728513A (en) | Granular delayed-release form of pharmaceutically active substances | |
| GB2087235A (en) | A granular delayed-release form of pharmaceutical active substances | |
| US4900557A (en) | Pellet formulation | |
| FI78835B (fi) | Foerfarande foer framstaellning av en ny dipyridamol-retardform. | |
| KR970007902B1 (ko) | 신규 테트라시클린 화합물의 조절된 방출 제재 | |
| KR880002673B1 (ko) | 진통 캡슐제와 그 제조방법 | |
| GB2176704A (en) | Solid, stable dosage forms with an elastic film coating | |
| CA2055905C (en) | Pharmaceutical composition comprising calcium polycarbophil | |
| US20010001658A1 (en) | Granule modulating hydrogel system | |
| WO2005009407A2 (en) | Oral pharmaceutical formulations of olanzapine | |
| US5492700A (en) | Process and composition for the development of controlled release gemfibrozil dosage form | |
| GB2155330A (en) | Solvent granulation technique for forming solid formulation of nystatin | |
| IE62643B1 (en) | Synergistic combination of decarboxylase inhibitors and L-dopa pellets | |
| US20040228918A1 (en) | Granule modulating hydrogel system | |
| KR100234446B1 (ko) | 하이드록시프로필 메틸셀룰로즈, 결합제, 소수성 성분 및 수용성 약제를 함유하는 서방성 정제 |